Commerzbank Analysts Give Rhoen Klinikum (RHK) a €25.00 Price Target

Commerzbank set a €25.00 ($29.07) target price on Rhoen Klinikum (ETR:RHK) in a research report released on Friday morning. The brokerage currently has a neutral rating on the stock.

A number of other research firms have also recently issued reports on RHK. Cfra set a €25.00 ($29.07) price objective on Rhoen Klinikum and gave the company a sell rating in a research report on Friday, August 3rd. Kepler Capital Markets set a €22.00 ($25.58) price target on Rhoen Klinikum and gave the stock a sell rating in a research report on Thursday, August 2nd. Warburg Research set a €25.20 ($29.30) price target on Rhoen Klinikum and gave the stock a neutral rating in a research report on Thursday, August 2nd. Credit Suisse Group set a €19.00 ($22.09) price target on Rhoen Klinikum and gave the stock a sell rating in a research report on Monday, August 6th. Finally, Berenberg Bank set a €27.75 ($32.27) price target on Rhoen Klinikum and gave the stock a neutral rating in a research report on Monday, August 6th. Five equities research analysts have rated the stock with a sell rating and six have given a hold rating to the stock. The stock presently has an average rating of Hold and an average target price of €24.10 ($28.02).

RHK traded up €0.66 ($0.77) during trading on Friday, reaching €22.76 ($26.47). 65,823 shares of the stock traded hands, compared to its average volume of 43,281. Rhoen Klinikum has a fifty-two week low of €25.08 ($29.16) and a fifty-two week high of €32.12 ($37.35).

Rhoen Klinikum Company Profile

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services primarily in the areas of cardiovascular, neurological disorders, oncology, pneumology, orthopedic, accident, and surgeries; rehabilitation and nursing services to the elderly; and thoracic, tumors, and psychosomatic, as well as spinal, column, and joints diseases.

Featured Story: Inflation

Analyst Recommendations for Rhoen Klinikum (ETR:RHK)

Receive News & Ratings for Rhoen Klinikum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhoen Klinikum and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply